File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pseudohypopyon Following Intravitreal Triamcinolone Acetonide Injection

TitlePseudohypopyon Following Intravitreal Triamcinolone Acetonide Injection
Authors
Sharma, MCLai, WWShapiro, MJ
KeywordsEndophthalmitis
Hypopyon
Intravitreal injection
Pseudohypopyon
Triamcinolone acetonide
Issue Date2004
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.corneajrnl.com/
Citation
Cornea, 2004, v. 23 n. 4, p. 398-399 How to Cite?
DOI: http://dx.doi.org/10.1097/00003226-200405000-00016
AbstractObjective: To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration. Methods: Observational case report. Results: A 62-year-old woman received an intravitreal injection of triamcinolone acetonide for the treatment of a choroidal neovascular membrane that developed as a result of age-related macular degeneration. A layer of yellowish deposits was observed in the anterior chamber 1 day after the injection. The patient denied any pain or reduced vision, and there was no redness noted on examination. The deposits cleared spontaneously on the fourth postoperative day. Conclusions: Pseudohypopyon may develop after intravitreal injection of triamcinolone acetonide. Distinguishing this from a true hypopyon is important because the treatment and prognosis are very different for the two conditions.
Persistent Identifierhttp://hdl.handle.net/10722/176420
ISSN
0277-3740
2023 Impact Factor: 1.9
2023 SCImago Journal Rankings: 1.019
ISI Accession Number ID
WOS:000221073400016
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorSharma, MCen_US
dc.contributor.authorLai, WWen_US
dc.contributor.authorShapiro, MJen_US
dc.date.accessioned2012-11-26T09:11:09Z-
dc.date.available2012-11-26T09:11:09Z-
dc.date.issued2004en_US
dc.identifier.citationCornea, 2004, v. 23 n. 4, p. 398-399en_US
dc.identifier.issn0277-3740en_US
dc.identifier.urihttp://hdl.handle.net/10722/176420-
dc.description.abstractObjective: To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration. Methods: Observational case report. Results: A 62-year-old woman received an intravitreal injection of triamcinolone acetonide for the treatment of a choroidal neovascular membrane that developed as a result of age-related macular degeneration. A layer of yellowish deposits was observed in the anterior chamber 1 day after the injection. The patient denied any pain or reduced vision, and there was no redness noted on examination. The deposits cleared spontaneously on the fourth postoperative day. Conclusions: Pseudohypopyon may develop after intravitreal injection of triamcinolone acetonide. Distinguishing this from a true hypopyon is important because the treatment and prognosis are very different for the two conditions.en_US
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.corneajrnl.com/en_US
dc.relation.ispartofCorneaen_US
dc.subjectEndophthalmitis-
dc.subjectHypopyon-
dc.subjectIntravitreal injection-
dc.subjectPseudohypopyon-
dc.subjectTriamcinolone acetonide-
dc.subject.meshAnterior Eye Segment - Drug Effects - Physiopathologyen_US
dc.subject.meshChoroidal Neovascularization - Drug Therapyen_US
dc.subject.meshEndophthalmitis - Chemically Induced - Physiopathologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlucocorticoids - Adverse Effectsen_US
dc.subject.meshHumansen_US
dc.subject.meshInjectionsen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshRemission, Spontaneousen_US
dc.subject.meshTriamcinolone Acetonide - Adverse Effectsen_US
dc.subject.meshVitreous Body - Drug Effectsen_US
dc.titlePseudohypopyon Following Intravitreal Triamcinolone Acetonide Injectionen_US
dc.typeArticleen_US
dc.identifier.emailLai, WW: wicolai@hku.hken_US
dc.identifier.authorityLai, WW=rp00531en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1097/00003226-200405000-00016en_US
dc.identifier.pmid15097137-
dc.identifier.scopuseid_2-s2.0-2142653620en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-2142653620&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume23en_US
dc.identifier.issue4en_US
dc.identifier.spage398en_US
dc.identifier.epage399en_US
dc.identifier.isiWOS:000221073400016-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridSharma, MC=7403269363en_US
dc.identifier.scopusauthoridLai, WW=7402231098en_US
dc.identifier.scopusauthoridShapiro, MJ=35447792900en_US
dc.identifier.issnl0277-3740-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats